O'Neal Katherine S, Murray Kelly A, Skomo Monica L, Carter Sandra M, McConaha Jamie
The University of Oklahoma HSC College of Pharmacy, 4502 E. 41st Street, Suite 2H26, Tulsa, OK 74135, USA.
The University of Oklahoma HSC College of Pharmacy, 4502 E. 41st Street, Suite 2H35, Tulsa, OK 74135, USA.
Res Social Adm Pharm. 2015 May-Jun;11(3):352-63. doi: 10.1016/j.sapharm.2014.08.012. Epub 2014 Oct 7.
Community pharmacists are in an ideal position to ameliorate migraineur under-consulting, under-diagnosis, and under-treatment. Contemporary education/training on developing therapeutic alliances with patients and in advanced pharmacotherapy may further motivate pharmacists to impact the care of migraineurs.
The objectives of this study were to assess pharmacists' perceptions of a migraine training program and their self-assessment of subsequent impact on patient care and to develop and assess a tool evaluating the impact of the training program from the patients' perspectives: (1) for patients diagnosed with migraines - identify perceptions of care by pharmacists who have undergone specialty training in migraine vs. pharmacists who have not; and (2) for patients with recurrent headaches and not diagnosed with migraines - identify perceptions of pharmacist effectiveness and thoroughness, after specialty training, to identify a potential migraine diagnosis and referral for advanced care vs. pharmacists that have not undergone specialty training.
This study employed a mixed method survey design using community pharmacies from the Tulsa, Oklahoma and Pittsburgh, Pennsylvania greater metropolitan areas. Pharmacists from intervention pharmacies received specialty training on migraine and were surveyed on their current practices and about the education program. Approximately 1 month after the training, control and intervention pharmacists were surveyed on current practices. Additionally, patients from both pharmacies were surveyed to assess Migraine Disability Assessment (MIDAS) and pharmacists' delivery of care derived from the Pharmacists' Care of Migraineurs Scale (PCMS). Surveys were handed out for a period of 3-months.
There were 16 pharmacists and 61 patients recruited. There was no difference in patient perceptions of pharmacists' care or in patient self-perceptions between migraineurs and recurrent headache sufferers. Ninety-two percent of pharmacists agreed that the program could be transferred to an internet-based educational program. The 14-item patient survey, however, demonstrated good internal consistency reliability, with each question having a Cronbach's alpha 0.80 or higher.
There are few studies evaluating the role and potential impact community pharmacists can have on patients suffering from migraines or recurrent headaches. While no difference was found between the groups, the internal reliability of the survey questions and the need to address needs of migraineurs warrants tool dissemination and a larger-scale study.
社区药剂师处于改善偏头痛患者咨询不足、诊断不足和治疗不足的理想位置。当代关于与患者建立治疗联盟以及高级药物治疗的教育/培训可能会进一步激励药剂师影响偏头痛患者的护理。
本研究的目的是评估药剂师对偏头痛培训项目的看法以及他们对后续患者护理影响的自我评估，并开发和评估一种从患者角度评估培训项目影响的工具：（1）对于被诊断为偏头痛的患者——确定接受过偏头痛专科培训的药剂师与未接受过培训的药剂师在护理方面的看法；（2）对于患有复发性头痛但未被诊断为偏头痛的患者——确定经过专科培训后，药剂师在识别潜在偏头痛诊断和转诊至高级护理方面的有效性和彻底性，与未接受过专科培训的药剂师相比。
本研究采用混合方法调查设计，使用俄克拉荷马州塔尔萨市和宾夕法尼亚州匹兹堡市大都市区的社区药房。来自干预药房的药剂师接受了偏头痛专科培训，并就他们当前的实践和教育项目进行了调查。培训后约1个月，对对照药房和干预药房的药剂师进行了当前实践调查。此外，对两家药房的患者进行了调查，以评估偏头痛残疾评估（MIDAS）和药剂师从偏头痛患者护理量表（PCMS）中得出的护理提供情况。调查发放为期3个月。
招募了16名药剂师和61名患者。偏头痛患者和复发性头痛患者对药剂师护理的看法以及患者的自我认知没有差异。92%的药剂师同意该项目可以转换为基于互联网的教育项目。然而，14项患者调查显示出良好的内部一致性信度，每个问题的克朗巴哈系数为0.80或更高。
很少有研究评估社区药剂师对偏头痛或复发性头痛患者的作用和潜在影响。虽然两组之间没有发现差异，但调查问题的内部信度以及满足偏头痛患者需求的必要性保证了工具的传播和更大规模的研究。
